Giorgio Walter Canonica Selected Research

Galectin 3 (LGALS3)

1/2020	Plasma Galectin-3 and urine proteomics predict FEV1 improvement in omalizumab-treated patients with severe allergic asthma: Results from the PROXIMA sub-study.
1/2017	Galectin-3: an early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36 months.
11/2014	Proteomics of bronchial biopsies: galectin-3 as a predictive biomarker of airway remodelling modulation in omalizumab-treated severe asthma patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giorgio Walter Canonica Research Topics

Disease

147	Asthma (Bronchial Asthma) 04/2024 - 04/2002
57	Hypersensitivity (Allergy) 04/2024 - 04/2002
34	Allergic Rhinitis 04/2024 - 07/2005
26	Inflammation (Inflammations) 04/2024 - 02/2005
22	Chronic Obstructive Pulmonary Disease (COPD) 03/2024 - 10/2007
18	Rhinitis 01/2024 - 03/2003
14	Rhinosinusitis 01/2024 - 06/2003
14	Nasal Polyps (Nasal Polyp) 12/2023 - 01/2019
11	Chronic Urticaria 01/2024 - 07/2005
9	Atopic Dermatitis (Atopic Eczema) 11/2023 - 07/2007
7	Urticaria (Hives) 01/2024 - 07/2005
7	Anaphylaxis (Anaphylactic Shock) 12/2023 - 04/2002
6	Infections 04/2023 - 02/2009
5	Food Hypersensitivity (Food Allergy) 05/2019 - 08/2005
5	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2019 - 09/2013
4	COVID-19 05/2023 - 01/2020
3	Dermatitis 11/2023 - 08/2005
3	Airway Remodeling 10/2023 - 11/2014
3	Bronchiectasis 08/2023 - 05/2019
3	Conjunctivitis 07/2023 - 03/2012
3	Headache (Headaches) 11/2022 - 01/2021
3	Cough 05/2022 - 01/2015
3	Sinusitis 01/2022 - 06/2004
3	Seasonal Allergic Rhinitis (Hay Fever) 01/2019 - 05/2009
2	Churg-Strauss Syndrome (Allergic Angiitis) 04/2023 - 05/2022
2	Chronic Cough 05/2022 - 12/2021
2	Fever (Fevers) 01/2022 - 01/2021
2	Eosinophilia 01/2022 - 01/2017
2	Eczema 01/2021 - 08/2005
2	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2015 - 09/2013
2	Bacterial Infections (Bacterial Infection) 01/2015 - 08/2010
1	AIDS-Related Complex (ARC) 12/2023

Drug/Important Bio-Agent (IBA)

48	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2024 - 08/2006
45	AllergensIBA 04/2024 - 01/2003
30	Immunoglobulin E (IgE)IBA 04/2024 - 01/2010
24	Omalizumab (Xolair)FDA Link 01/2024 - 07/2007
19	Biomarkers (Surrogate Marker)IBA 03/2024 - 11/2014
14	mepolizumabIBA 01/2024 - 01/2016
12	CytokinesIBA 01/2024 - 06/2003
11	benralizumabIBA 01/2024 - 01/2016
10	Interleukin-5 (Interleukin 5)IBA 01/2024 - 01/2017
10	Monoclonal AntibodiesIBA 04/2023 - 07/2007
9	TabletsIBA 01/2024 - 04/2014
9	VaccinesIBA 04/2023 - 08/2008
9	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2022 - 08/2011
8	dupilumabIBA 12/2023 - 01/2016
8	SteroidsIBA 12/2023 - 08/2006
8	anti-IgE antibodiesIBA 01/2023 - 11/2014
6	Interleukin-13IBA 08/2023 - 09/2002
6	Histamine Antagonists (Antihistamines)IBA 01/2023 - 07/2005
6	Muscarinic AntagonistsIBA 12/2022 - 06/2017
6	Formoterol Fumarate (Oxis)FDA Link 01/2022 - 01/2010
5	Bronchodilator Agents (Bronchodilators)IBA 05/2023 - 06/2005
4	Arthropod VenomsIBA 01/2022 - 01/2009
4	Fluticasone (Cutivate)FDA LinkGeneric 12/2020 - 01/2010
4	Proteins (Proteins, Gene)FDA Link 01/2017 - 10/2007
3	3- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA 04/2024 - 01/2021
3	bilastineIBA 01/2024 - 04/2014
3	InterleukinsIBA 08/2023 - 01/2016
3	GoldIBA 12/2022 - 10/2007
3	azelastine (Optivar)FDA LinkGeneric 12/2020 - 04/2014
3	reslizumabIBA 01/2020 - 01/2016
3	Galectin 3 (LGALS3)IBA 01/2020 - 11/2014
3	rupatadineIBA 01/2019 - 11/2013
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 08/2010
3	Environmental Pollutants (Pollutants, Environmental)IBA 01/2018 - 02/2009
3	GlucocorticoidsIBA 01/2016 - 09/2011
3	Bacterial LysatesIBA 08/2015 - 08/2010
3	Broncho-VaxomIBA 08/2015 - 01/2013
3	levocetirizine FDA LinkGeneric 10/2009 - 07/2005
2	Tryptases (Tryptase)IBA 04/2024 - 01/2022
2	Non-Sedating Histamine H1 Antagonists (Histamine H1 Antagonists, Non Sedating)IBA 01/2024 - 01/2017
2	Immunoglobulin G (IgG)IBA 05/2023 - 01/2019
2	Immunoglobulin A (IgA)IBA 05/2023 - 01/2019
2	Excipients (Suspending Agents)IBA 04/2023 - 04/2023
2	mRNA VaccinesIBA 04/2023 - 04/2023
2	Polysorbates (PSML)FDA Link 04/2023 - 05/2021
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 04/2023 - 05/2021
2	COVID-19 VaccinesIBA 05/2022 - 05/2021
2	Interleukin-4 (Interleukin 4)IBA 01/2022 - 01/2016
2	VenomsIBA 01/2022 - 02/2020
2	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2021 - 10/2020
2	Beclomethasone (Beclometasone)FDA Link 01/2021 - 10/2020
2	Tiotropium Bromide (Spiriva)FDA Link 01/2020 - 11/2019
2	PeriostinIBA 01/2017 - 01/2016
2	Budesonide (Pulmicort)FDA LinkGeneric 10/2015 - 01/2009
2	Histamine (Histamine Dihydrochloride)FDA Link 06/2014 - 07/2005
2	SolutionsIBA 04/2014 - 06/2013
2	LatexIBA 01/2013 - 09/2012
1	Eosinophil Cationic ProteinIBA 04/2024
1	Prednisone (Sone)FDA LinkGeneric 01/2024
1	trichostatin A (A 300)IBA 12/2023
1	ligelizumabIBA 11/2023
1	Anti-Asthmatic Agents (Antiasthmatic Drugs)IBA 10/2023

Therapy/Procedure

69	Therapeutics 04/2024 - 10/2003
32	Immunotherapy 12/2023 - 04/2002
14	Precision Medicine 10/2023 - 01/2016
11	Nebulizers and Vaporizers (Inhaler) 12/2022 - 09/2013
8	Biological Therapy 02/2024 - 05/2020
8	Drug Therapy (Chemotherapy) 05/2022 - 11/2003